EntryPoint Capital’s Roivant Sciences ROIV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $129K | Sell |
11,419
-34,661
| -75% | -$391K | 0.06% | 546 |
|
|
2025
Q1 | $465K | Sell |
46,080
-7,363
| -14% | -$74.3K | 0.21% | 122 |
|
|
2024
Q4 | $632K | Buy |
53,443
+40,964
| +328% | +$485K | 0.27% | 43 |
|
|
2024
Q3 | $144K | Buy |
12,479
+11,331
| +987% | +$131K | 0.08% | 519 |
|
|
2024
Q2 | $12.1K | Buy |
+1,148
| New | +$12.1K | 0.02% | 751 |
|
|
2024
Q1 | – | Sell |
-8,323
| Closed | -$93.5K | – | 1702 |
|
|
2023
Q4 | $93.5K | Buy |
+8,323
| New | +$93.5K | 0.09% | 413 |
|